John Libbey Eurotext

European Journal of Dermatology

MENU

Origanum essential oils reduce the level of melanin in B16-F1 melanocytes Article à paraître

Illustrations

  • Figure 1
  • Figure 2
  • Figure 3
  • Figure 4
  • Figure 5
Auteurs
1 Unité de Technologie et Valorisation Alimentaire, Centre d’Analyses et de Recherche, Université Saint-Joseph, Campus des Sciences et Technologies, Mar Roukos, Mkallès, P.O Box 11- 514, Riad El Solh, 1107 2050 Beirut, Lebanon
2 Interdisciplinary Unit: Lipids, Analytical and Biological Systems Lip(Sys)2, Faculty of Pharmacy, Univ Paris-Sud, Univ Paris-Saclay, F-92290 Châtenay-Malabry, France
3 Obegi Chemicals, Esseily building, P.O. Box 11-2652, Riad el Solh, Beirut, Lebanon
* Reprints
  • Mots-clés : anti-tyrosinase activity, carvacrol, competitive inhibition, melanocyte, melanogenesis inhibitor, Origanum essential oil
  • DOI : 10.1684/ejd.2019.3677

Background: Hyperpigmentation disorders are considered signs of skin aging and are aesthetically unpleasant. Most active ingredients used against hyperpigmentation disorders predominantly target tyrosinase activity. Objective: To study the effect of two Origanum essential oils on the melanogenic activity of B16-F1 murine melanocytes. The main component of these oils, carvacrol, was also investigated and a model for anti-melanogenic activity is proposed. Materials and Methods: B16-F1 melanocytes were exposed to different concentrations of essential oils and carvacrol. The level of tyrosinase and melanin was determined using spectrophotometric measurements. Results: Essential oils of Origanum syriacum and Origanum ehrenbergii led to a significant 14% and 17% reduction in melanin level at 40 μg mL-1, respectively. However, neither demonstrated a significant effect on the level of intracellular tyrosinase. The same effects were found for carvacrol which led to a 30% reduction in melanin at 45 μg mL-1. Conclusion: Our results indicate that the oils studied are anti-melanogenic. We propose a mechanism, similar to that for hydroquinone, whereby carvacrol functions as a competitive inhibitor of tyrosinase, thus inhibiting oxidation of tyrosine and causing a deregulation of melanogenesis.